Effectiveness of COVID-19 Vaccine (Vero Cell), Inactivated (CoronaVac) for Preventing Symptomatic SARS-CoV-2 Infections and Hospitalizations in the Dominican Republic - Test-Negative Case-Control Study
Latest Information Update: 25 Aug 2022
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors Sinovac Biotech
Most Recent Events
- 21 Aug 2022 Status changed from recruiting to completed.
- 22 Oct 2021 Planned End Date changed from 11 Apr 2022 to 17 Apr 2022.
- 22 Oct 2021 Planned primary completion date changed from 11 Nov 2021 to 17 Nov 2021.